In 10 Years, Will You Wish You'd Bought NuScale Power Stock Right Now?

NuScale Power is positioned as the only NRC-approved SMR developer, with its first commercial deployments potentially coming in the next five years and revenue projected to rise more than 900% over the next two years. The article highlights a $4 billion market cap against about $31.5 million in trailing 12-month revenue, but also notes meaningful execution risk and the lack of a firm sale. Overall, the piece is bullish on NuScale's long-term opportunity tied to AI-driven power demand and nuclear grid expansion.

Analysis

The market is likely overpaying for the optionality and underpricing the cash conversion problem. SMR’s real edge is not the technology itself but the regulatory sequencing advantage: that can compress competitor timelines by years, but it does not compress customer procurement cycles, financing, and construction risk. In this kind of pre-revenue infrastructure story, the next rerating is more likely to come from a binding customer milestone than from headline TAM claims; until then, valuation will trade like a call option on policy and capital-market patience rather than a utility asset.

The second-order winner set is broader than SMR. If SMR becomes the reference design for AI-adjacent power, engineering, permitting, and balance-sheet partners with de-risked project exposure should benefit before the reactor OEM does. That favors firms with construction, grid interconnect, and project-finance leverage; it also raises the bar for competing reactor developers that still need licensing credibility, because every month SMR stays “the only approved” design increases customer inertia and raises the switching cost of waiting.

The main risk is that the stock’s current discount rate is too low for a multi-year execution path with binary outcomes. A single delay, cost overrun, or financing reset on the first deployment would likely compress the multiple sharply because the market is capitalizing future optionality, not current earnings. Conversely, if the first signed U.S. deal is with a utility/industrial anchor and includes customer prepayments or a credible project-finance structure, the stock could rerate much faster than revenue growth alone would justify.

The contrarian takeaway is that the bull case is probably right on direction but wrong on timing. The most important bottleneck may not be reactor approval; it may be the willingness of buyers to accept long-dated power-delivery risk in exchange for a strategic hedge against grid scarcity. That means the upside is real, but the path is likely punctuated by long flat periods where momentum investors get shaken out before the first meaningful revenue inflection.

Key Decisions for Investors

• Maintain a tactical long in SMR only on pullbacks; treat it as a multi-year option, not a core compounder. Risk/reward improves materially below prior breakout levels, but position size should stay small because a 20-30% drawdown on any project delay is plausible.
• Pair trade: long engineering/procurement names with nuclear project exposure vs. short speculative pre-cash-flow reactor developers. The winner should be the company that monetizes project management and permitting while others absorb licensing and financing risk.
• For event-driven exposure, buy SMR call spreads only around concrete catalyst windows such as first customer award or financing announcement; avoid outright stock into periods with no near-term milestones because theta is the enemy in a story stock.
• Fade exuberance if the tape starts pricing the first deployment as if it were already de-risked. Any announcement that is non-binding, conditional, or heavily subsidy-dependent should be treated as a sell-the-news event, not a fundamental inflection.